Cargando…
Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation
The protective effects of carbon monoxide (CO) against ischemia/reperfusion (IR) injury during organ transplantation have been extensively investigated. Likewise, CO-releasing molecules (CORMs) are known to exert a variety of pharmacological activities via liberation of controlled amounts of CO in o...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213078/ https://www.ncbi.nlm.nih.gov/pubmed/34966108 http://dx.doi.org/10.1097/TP.0000000000004007 |
_version_ | 1784730755556966400 |
---|---|
author | Obara, Takafumi Yamamoto, Hirotsugu Aokage, Toshiyuki Igawa, Takuro Nojima, Tsuyoshi Hirayama, Takahiro Seya, Mizuki Ishikawa-Aoyama, Michiko Nakao, Atsunori Motterlini, Roberto Naito, Hiromichi |
author_facet | Obara, Takafumi Yamamoto, Hirotsugu Aokage, Toshiyuki Igawa, Takuro Nojima, Tsuyoshi Hirayama, Takahiro Seya, Mizuki Ishikawa-Aoyama, Michiko Nakao, Atsunori Motterlini, Roberto Naito, Hiromichi |
author_sort | Obara, Takafumi |
collection | PubMed |
description | The protective effects of carbon monoxide (CO) against ischemia/reperfusion (IR) injury during organ transplantation have been extensively investigated. Likewise, CO-releasing molecules (CORMs) are known to exert a variety of pharmacological activities via liberation of controlled amounts of CO in organs. Therefore, we hypothesized that intraluminal administration of water-soluble CORM-3 during cold storage of intestinal grafts would provide protective effects against IR injury. METHODS. Orthotopic syngeneic intestinal transplantation was performed in Lewis rats following 6 h of cold preservation in Ringer solution or University of Wisconsin solution. Saline containing CORM-3 (100 µmol/L) or its inactive counterpart (iCORM-3) was intraluminally introduced in the intestinal graft before cold preservation. RESULTS. Histopathological analysis of untreated and iCORM-3–treated grafts revealed a similar erosion and blunting of the intestinal villi. These changes in the mucosa structure were significantly attenuated by intraluminal administration of CORM-3. Intestinal mucosa damage caused by IR injury led to considerable deterioration of gut barrier function 3 h postreperfusion. CORM-3 significantly inhibited upregulation of proinflammatory mRNA levels, ameliorated intestinal morphological changes, and improved graft blood flow and mucosal barrier function. Additionally, CORM-3–treated grafts increased recipient survival rates. Pharmacological blockade of soluble guanylyl cyclase activity significantly reversed the protective effects conferred by CORM-3, indicating that CO partially mediates its therapeutic actions via soluble guanylyl cyclase activation. CONCLUSIONS. Our study demonstrates that luminally delivered CORM-3 provides beneficial effects in cold-stored rat small intestinal grafts and could be an attractive therapeutic application of CO in the clinical setting of organ preservation and transplantation. |
format | Online Article Text |
id | pubmed-9213078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-92130782022-06-23 Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation Obara, Takafumi Yamamoto, Hirotsugu Aokage, Toshiyuki Igawa, Takuro Nojima, Tsuyoshi Hirayama, Takahiro Seya, Mizuki Ishikawa-Aoyama, Michiko Nakao, Atsunori Motterlini, Roberto Naito, Hiromichi Transplantation Original Basic Science—General The protective effects of carbon monoxide (CO) against ischemia/reperfusion (IR) injury during organ transplantation have been extensively investigated. Likewise, CO-releasing molecules (CORMs) are known to exert a variety of pharmacological activities via liberation of controlled amounts of CO in organs. Therefore, we hypothesized that intraluminal administration of water-soluble CORM-3 during cold storage of intestinal grafts would provide protective effects against IR injury. METHODS. Orthotopic syngeneic intestinal transplantation was performed in Lewis rats following 6 h of cold preservation in Ringer solution or University of Wisconsin solution. Saline containing CORM-3 (100 µmol/L) or its inactive counterpart (iCORM-3) was intraluminally introduced in the intestinal graft before cold preservation. RESULTS. Histopathological analysis of untreated and iCORM-3–treated grafts revealed a similar erosion and blunting of the intestinal villi. These changes in the mucosa structure were significantly attenuated by intraluminal administration of CORM-3. Intestinal mucosa damage caused by IR injury led to considerable deterioration of gut barrier function 3 h postreperfusion. CORM-3 significantly inhibited upregulation of proinflammatory mRNA levels, ameliorated intestinal morphological changes, and improved graft blood flow and mucosal barrier function. Additionally, CORM-3–treated grafts increased recipient survival rates. Pharmacological blockade of soluble guanylyl cyclase activity significantly reversed the protective effects conferred by CORM-3, indicating that CO partially mediates its therapeutic actions via soluble guanylyl cyclase activation. CONCLUSIONS. Our study demonstrates that luminally delivered CORM-3 provides beneficial effects in cold-stored rat small intestinal grafts and could be an attractive therapeutic application of CO in the clinical setting of organ preservation and transplantation. Lippincott Williams & Wilkins 2021-12-27 2022-07 /pmc/articles/PMC9213078/ /pubmed/34966108 http://dx.doi.org/10.1097/TP.0000000000004007 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Basic Science—General Obara, Takafumi Yamamoto, Hirotsugu Aokage, Toshiyuki Igawa, Takuro Nojima, Tsuyoshi Hirayama, Takahiro Seya, Mizuki Ishikawa-Aoyama, Michiko Nakao, Atsunori Motterlini, Roberto Naito, Hiromichi Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation |
title | Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation |
title_full | Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation |
title_fullStr | Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation |
title_full_unstemmed | Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation |
title_short | Luminal Administration of a Water-soluble Carbon Monoxide–releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation |
title_sort | luminal administration of a water-soluble carbon monoxide–releasing molecule (corm-3) mitigates ischemia/reperfusion injury in rats following intestinal transplantation |
topic | Original Basic Science—General |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213078/ https://www.ncbi.nlm.nih.gov/pubmed/34966108 http://dx.doi.org/10.1097/TP.0000000000004007 |
work_keys_str_mv | AT obaratakafumi luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT yamamotohirotsugu luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT aokagetoshiyuki luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT igawatakuro luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT nojimatsuyoshi luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT hirayamatakahiro luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT seyamizuki luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT ishikawaaoyamamichiko luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT nakaoatsunori luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT motterliniroberto luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation AT naitohiromichi luminaladministrationofawatersolublecarbonmonoxidereleasingmoleculecorm3mitigatesischemiareperfusioninjuryinratsfollowingintestinaltransplantation |